American Society of Clinical Oncology - Clinical Cancer Advances 2017

Advance of the Year: Immunotherapy 2.0

Advances in Cancer Treatment Beyond Immunotherapy

Advances in Pacient Care

Advances in Tumor Biology

Cancer Risk, Prevention, and Screening

Looking to the Future

Cancer Risk, Prevention, and Screening - -

Artigo	Autor(es)	Referência
Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.	Holter Spring, Borgida Ayelet, Dodd Anna, Grant Robert, Semotiuk Kara, Hedley David, Dhani Neesha, Narod Steven, Akbari Mohammad, Moore Malcolm, Gallinger Steven	Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Oct; 33(Oct):3124-9. doi: 10.1200/JCO.2014.59.7401. pii: .

Nenhuma revista foi definida para este congresso.

Combined Modality Therapy	-
Longer Hormone Therapy Further Reduces Breast Cancer Recurrence	-
New Concerns About Laparoscopic Rectal Cancer Surgery	-
Targeted Therapy	-

Addressing Health Literacy in The Era of Precision Medicine	-
Better Way to Prevent Chemotherapy-Triggered Nause	-
Patient Navigation Program Improves Compliance With Cancer Therapy	-
Patient Self-Reporting of Symptoms Improves Care	-

Additional Genes Linked to Ovarian Cancer Risk	-
Broader Testing Uncovers Unexpected Cancer Predisposition Gene Mutations	-
Daily Vitamin B Reduces Skin Cancer Risk	-
Many Children With Cancer May Carry Hereditary Gene Mutations	-
New Understanding of Barriers to Cancer Screening Among Latinas	-
Pancreatic Cancer Susceptibility Genes Identified, and New Opportunities for Screening and Prevention	-

Checkpoint Inhibitors work well Against Hypermutated Cancers	-
Emerging Clues on Patient Selection	-
Progress With Immune Checkpoint Inhibitors 10	-

Expanding Targeted Therapy Options for Ovarian Cancer	-
Liquid Biopsies Help Personalize Cancer Therapy	-